Statement of Organization, Functions, and Delegations of Authority, 71808 [2015-29282]
Download as PDF
<![CDATA[
71808
Federal Register / Vol. 80, No. 221 / Tuesday, November 17, 2015 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–29257 Filed 11–16–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 80 FR 58479–58485,
dated September 29, 2015) is amended
to reflect the reorganization of the
National Center for Immunization and
Respiratory Diseases, and the Office of
Infectious Diseases, Centers for Disease
Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and
function statements for the Influenza
Coordination Unit (CVA4).
Delete in its entirety the title and
function statements for the National
Center for Immunization and
Respiratory Diseases (CVG) and insert
the following:
National Center for Immunization
and Respiratory Diseases (CVG). The
National Center for Immunization and
Respiratory Diseases (NCIRD) prevents
disease, disability, and death through
immunization and by control of
respiratory and related diseases. In
carrying out its mission, NCIRD: (1)
Provides leadership, expertise, and
service in laboratory and
epidemiological sciences, and in
immunization program delivery; (2)
conducts applied research on disease
prevention and control; (3) translates
research findings into public health
policies and practices; (4) provides
diagnostic and reference laboratory
services to relevant partners; (5)
conducts surveillance and research to
determine disease distribution,
determinants, and burden nationally
and internationally; (6) responds to
disease outbreaks domestically and
abroad; (7) ensures that public health
VerDate Sep<11>2014
18:14 Nov 16, 2015
Jkt 238001
decisions are made objectively and
based upon the highest quality of
scientific data; (8) provides technical
expertise, education, and training to
domestic and international partners; (9)
provides leadership to internal and
external partners for establishing and
maintaining immunization, and other
prevention and control programs; (10)
develops, implements, and evaluates
domestic and international public
health policies; (11) communicates
information to increase awareness,
knowledge, and understanding of public
health issues domestically and
internationally, and to promote effective
immunization programs; (12) aligns the
national center focus with the overall
strategic goals of CDC; (13) synchronizes
all aspects of CDC’s pandemic influenza
preparedness and response from
strategy through implementation and
evaluation; and (14) implements,
coordinates, and evaluates programs
across NCIRD, Office of Infectious
Diseases (OID), and CDC to optimize
public health impact.
Delete in its entirety the title and
function statements for the Office of
Laboratory Science (CVG14).
After the Office of Science and
Integrated Programs (CVG17) insert the
following:
Influenza Coordination Unit (CVG18).
The mission of the Influenza
Coordination Unit (ICU) is to
synchronize all aspects of CDC’s
pandemic influenza preparedness and
response from strategy through
implementation and evaluation. In
carrying out its mission, the ICU: (1)
Serves as the principal advisor to the
CDC Director on pandemic influenza
preparedness and response activities,
assisting the Director in formulating and
communicating strategic pandemic
initiatives and policies; (2) provides
strategic leadership for CDC in the areas
of pandemic preparedness and
response, including setting priorities
and promoting science, policies, and
programs related to pandemic influenza;
(3) strategically manages a budget and
allocates funds across the agency to
ensure appropriate resources for high
priority areas; and (4) conducts ongoing
evaluation and adjustment of pandemic
preparedness and response activities, in
coordination with the National
Response Framework and other
emergency preparedness guidance, to
ensure optimal public health
effectiveness and efficient use of human
and fiscal resources by developing and
leading an exercise program for the
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Agency, in collaboration with HHS and
other partners.
James Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2015–29282 Filed 11–16–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date:
8:30 a.m.–5:00 p.m., EST, December 9, 2015
8:00 a.m.–12:00 p.m., EST, December 10,
2015
Place: CDC, Global Communications Center,
1600 Clifton Road, NE., Building 19,
Auditorium B3, Atlanta, Georgia 30333.
Status: The meeting is open to the public,
limited only by the space available.
Purpose: The BSC, OID, provides advice
and guidance to the Secretary, Department of
Health and Human Services; the Director,
CDC; the Director, OID; and the Directors of
the National Center for Immunization and
Respiratory Diseases, the National Center for
Emerging and Zoonotic Infectious Diseases,
and the National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, CDC, in
the following areas: Strategies, goals, and
priorities for programs; research within the
national centers; and overall strategic
direction and focus of OID and the national
centers.
Matters for Discussion: The meeting will
include reports from the Board’s Food Safety
Modernization Act Surveillance Working
Group and Infectious Disease Laboratory
Working Group; brief updates on selected
activities of CDC’s infectious disease national
centers; and updates and focused discussions
on prevention of Legionella disease and
efforts to better understand and address
environmental factors contributing to
infectious disease outbreaks.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robin Moseley, M.A.T., Designated Federal
Officer, OID, CDC, 1600 Clifton Road NE.,
Mailstop D10, Atlanta, Georgia 30333,
Telephone: (404) 639–4461.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\17NON1.SGM
17NON1
]]>Agencies
[Federal Register Volume 80, Number 221 (Tuesday, November 17, 2015)]
[Notices]
[Page 71808]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29282]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 80 FR 58479-58485, dated September 29, 2015)
is amended to reflect the reorganization of the National Center for
Immunization and Respiratory Diseases, and the Office of Infectious
Diseases, Centers for Disease Control and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the title and function statements for the
Influenza Coordination Unit (CVA4).
Delete in its entirety the title and function statements for the
National Center for Immunization and Respiratory Diseases (CVG) and
insert the following:
National Center for Immunization and Respiratory Diseases (CVG).
The National Center for Immunization and Respiratory Diseases (NCIRD)
prevents disease, disability, and death through immunization and by
control of respiratory and related diseases. In carrying out its
mission, NCIRD: (1) Provides leadership, expertise, and service in
laboratory and epidemiological sciences, and in immunization program
delivery; (2) conducts applied research on disease prevention and
control; (3) translates research findings into public health policies
and practices; (4) provides diagnostic and reference laboratory
services to relevant partners; (5) conducts surveillance and research
to determine disease distribution, determinants, and burden nationally
and internationally; (6) responds to disease outbreaks domestically and
abroad; (7) ensures that public health decisions are made objectively
and based upon the highest quality of scientific data; (8) provides
technical expertise, education, and training to domestic and
international partners; (9) provides leadership to internal and
external partners for establishing and maintaining immunization, and
other prevention and control programs; (10) develops, implements, and
evaluates domestic and international public health policies; (11)
communicates information to increase awareness, knowledge, and
understanding of public health issues domestically and internationally,
and to promote effective immunization programs; (12) aligns the
national center focus with the overall strategic goals of CDC; (13)
synchronizes all aspects of CDC's pandemic influenza preparedness and
response from strategy through implementation and evaluation; and (14)
implements, coordinates, and evaluates programs across NCIRD, Office of
Infectious Diseases (OID), and CDC to optimize public health impact.
Delete in its entirety the title and function statements for the
Office of Laboratory Science (CVG14).
After the Office of Science and Integrated Programs (CVG17) insert
the following:
Influenza Coordination Unit (CVG18). The mission of the Influenza
Coordination Unit (ICU) is to synchronize all aspects of CDC's pandemic
influenza preparedness and response from strategy through
implementation and evaluation. In carrying out its mission, the ICU:
(1) Serves as the principal advisor to the CDC Director on pandemic
influenza preparedness and response activities, assisting the Director
in formulating and communicating strategic pandemic initiatives and
policies; (2) provides strategic leadership for CDC in the areas of
pandemic preparedness and response, including setting priorities and
promoting science, policies, and programs related to pandemic
influenza; (3) strategically manages a budget and allocates funds
across the agency to ensure appropriate resources for high priority
areas; and (4) conducts ongoing evaluation and adjustment of pandemic
preparedness and response activities, in coordination with the National
Response Framework and other emergency preparedness guidance, to ensure
optimal public health effectiveness and efficient use of human and
fiscal resources by developing and leading an exercise program for the
Agency, in collaboration with HHS and other partners.
James Seligman,
Acting Chief Operating Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2015-29282 Filed 11-16-15; 8:45 am]
BILLING CODE 4163-18-P
